BLRX

BioLineRX
BLRX

Overview Fund Activity

26 hedge funds and large institutions have $41M invested in BioLineRX in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FI
1
Fosun International
China
$1.41M
2
EMG
2
ETF Managers Group
New Jersey
$224K
3
SAM
3
Sectoral Asset Management
Quebec, Canada
$212K
4
FWM
4
Focused Wealth Management
New York
$38K
5
CS
5
Credit Suisse
Switzerland
$33K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$1.03M
3
Commonwealth Equity Services
3
Commonwealth Equity Services
Massachusetts
$55K
4
Creative Planning
4
Creative Planning
Kansas
$11K
5
SM
5
Senvest Management
New York
$8.28M
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$1K – – –
RE
27
RBC Europe
United Kingdom
$214 -$178 – –
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$98K -180 Closed
ARTA
29
A.R.T. Advisors
New York
– -$15K -28 Closed
Ameriprise
30
Ameriprise
Minnesota
– -$9K -18 Closed
UBS Group
31
UBS Group
Switzerland
– -$7K -13 Closed
CF
32
Centaurus Financial
California
– -$6K -12 Closed
ML
33
McAdam LLC
Pennsylvania
– -$3K -6 Closed
1
2